1314400-71-9 Usage
Uses
Used in Organic Chemistry:
(S)-tert-butyl 3-(1-hydroxyethyl)pyrrolidine-1-carboxylate is used as a chiral auxiliary for enhancing the selectivity and efficiency of asymmetric reactions. Its application reason is the presence of the chiral center in the pyrrolidine ring, which can influence the stereochemistry of the reactions it participates in, leading to the preferential formation of one enantiomer over the other.
Used in Pharmaceutical Synthesis:
In the pharmaceutical industry, (S)-tert-butyl 3-(1-hydroxyethyl)pyrrolidine-1-carboxylate is used as a key intermediate for the synthesis of various pharmaceutical compounds. The application reason is its unique structural features, which can be strategically modified to produce a range of biologically active molecules with potential therapeutic applications.
Used in Synthesis of Organic Molecules:
(S)-tert-butyl 3-(1-hydroxyethyl)pyrrolidine-1-carboxylate is also used as a versatile building block in the synthesis of a diverse array of organic molecules. The application reason is its reactivity and the ability to be functionalized further, making it a valuable component in the creation of complex organic structures for various applications, including materials science and specialty chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 1314400-71-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,4,4,0 and 0 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1314400-71:
(9*1)+(8*3)+(7*1)+(6*4)+(5*4)+(4*0)+(3*0)+(2*7)+(1*1)=99
99 % 10 = 9
So 1314400-71-9 is a valid CAS Registry Number.
1314400-71-9Relevant academic research and scientific papers
COMPOUNDS, COMPOSITIONS AND METHODS FOR SYNTHESIS
-
Paragraph 001607; 001608; 001609; 001610, (2019/01/10)
The present disclosure, among other things, provides technologies for synthesis, including reagents and methods for stereoselective synthesis. In some embodiments, the present disclosure provides compounds useful as chiral auxiliaries. In some embodiments, the present disclosure provides reagents and methods for oligonucleotide synthesis. In some embodiments, the present disclosure provides reagents and methods for chirally controlled preparation of oligonucleotides. In some embodiments, technologies of the present disclosure are particularly useful for constructing challenging internucleotidic linkages, providing high yields and stereoselectivity.
SUBSTITUTED PYRIDOPYRAZINES AS NOVEL SYK INHIBITORS
-
Page/Page column 80, (2013/02/27)
Provided are certain pyridopyrazine compounds, pharmaceutical compositions thereof and methods of use therefor.
